The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Key Points: Runx factors are critical for HSC function, preventing HSC exhaustion by maintaining levels of PU.1. Runx factors are required for leukemia survival by maintaining the stemness of leukemic cells through their downstream target PU.1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PU.1 is expressed in HSC and exhibits a gradual decrease during the subsequent differentiation into common lymphoid and myeloid progenitors.33”
From PELI2 regulates early B-cell progenitor differentiation and related leukemia via the IL-7R expression (2023) · cites this paper as [33]
Citations
Cites
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Prognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia
Valk, P. J. M., Verhaak, R. G. W., Beijen, M. A., Erpelinck, C. A. J., van Doorn-Khosrovani, S. B. V. W., Boer, J. M., Beverloo, H. B., Moorhouse, M. J., van der Spek, P. J., Löwenberg, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040465 · Cited by 1,370 · cited 2×
“We first evaluated the relative PU.1 expression in leukemia patients by using the gene expression data set (Affymetrix U133A GeneChips) of the Erasmus Rotterdam cohort comprising 285 well-characterized patients with AML.37 PU.1 expression is shown as black bars in respect to hierarchical clusters that reflect distinct…”
MethodSelf-citationRunx1 is required for the endothelial to haematopoietic cell transition but not thereafter
Chen, M. J., Yokomizo, T., Zeigler, B. M., Dzierzak, E., & Speck, N. A. (2009) · Nature · doi:10.1038/nature07619 · Cited by 1,013
Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., & Ohki, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10431 · Cited by 872
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Bernt, K. M., Zhu, N., Sinha, A. U., Vempati, S., Faber, J., Krivtsov, A. V., Feng, Z., Punt, N., Daigle, A., Bullinger, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.010 · Cited by 870 · cited 1×
“The functional redundancy of Runx factors was further supported by a report showing Runx2 upregulation in MLL-AF9 leukemia.(40) By disrupting the common binding sequences of all Runx family members in the PU.”
BackgroundThe haemangioblast generates haematopoietic cells through a haemogenic endothelium stage
Lancrin, C., Sroczynska, P., Stephenson, C., Allen, T., Kouskoff, V., & Lacaud, G. (2009) · Nature · doi:10.1038/nature07679 · Cited by 633
Disruption of differentiation in human cancer: AML shows the way
Tenen, D. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc989 · Cited by 612 · cited 1×
“1 strongly promotes myeloid differentiation, it has been thought to be a leukemia-suppressive gene.(42) Reducing PU.”
BackgroundSelf-citationIchikawa, M., Asai, T., Saito, T., Yamamoto, G., Seo, S., Yamazaki, I., Yamagata, T., Mitani, K., Chiba, S., Hirai, H., et al. (2004) · Nature Medicine · doi:10.1038/nm997 · Cited by 596 · cited 5×
“Previous reports of Runx1 function in HSCs have been inconsistent, probably due to partial compensatory effects of other Runx family members.21-24 Here we show that Runx1 deletion led to Runx3 upregulation in HSCs.”
BackgroundInfluentialContinuous single-cell imaging of blood generation from haemogenic endothelium
Eilken, H. M., Nishikawa, S.-I., & Schroeder, T. (2009) · Nature · doi:10.1038/nature07760 · Cited by 569
Cited by
Role of RUNX1 in hematological malignancies
Sood, R., Kamikubo, Y., & Liu, P. (2017) · Blood · doi:10.1182/blood-2016-10-687830 · Cited by 494
“1 in hematopoietic cells, which is important for leukemia development byRUNX1-RUNX1T1 in amurine transplantationmodel.(183) Interestingly, Goyama and colleagues found that RUNX1may also be required by leukemia cells with MLL fusion genes.”
BackgroundPharmacological inhibition of the transcription factor PU.1 in leukemia
Antony-Debré, I., Paul, A., Leite, J., Mitchell, K., Kim, H. M., Carvajal, L. A., Todorova, T. I., Huang, K., Kumar, A., Farahat, A. A., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92504 · Cited by 120
“1 expression or activity is present in more than 50% of patients with AML and is associated with a specific transcriptional and epigenetic program (19, 20).”
BackgroundHematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia
Ye, M., Zhang, H., Yang, H., Koche, R., Staber, P. B., Cusan, M., Levantini, E., Welner, R. S., Bach, C. S., Zhang, J., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.08.011 · Cited by 117
“Next we measured the frequency of C/EBPa KO LSCs by performing limiting dilution transplantation assays (Staber et al., 2014).”
Self-citationRUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1
Mill, C. P., Fiskus, W. C., Dinardo, C. D., Qian, Y., Raina, K., Rajapakshe, K., Perera, D. N., Coarfa, C., Kadia, T. M., Khoury, J. D., et al. (2019) · Blood · doi:10.1182/blood.2018893982 · Cited by 106
The RUNX1–PU.1 axis in the control of hematopoiesis
Imperato, M. R., Cauchy, P., Obier, N., & Bonifer, C. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1762-8 · Cited by 94
Metadata
- Authors
- Staber, P. B., Zhang, P., Ye, M., Welner, R. S., Levantini, E., Di Ruscio, A., Ebralidze, A. K., Bach, C., Zhang, H., Zhang, J., Vanura, K., Delwel, R., Yang, H., Huang, G., & Tenen, D. G.
- Affiliations
- Harvard University (US)
- Harvard Stem Cell Institute, Harvard Medical School, Boston, MA;
- Comprehensive Cancer Center Vienna (AT)
- Erasmus MC (NL)
- National University of Singapore (SG)
- Cincinnati Children's Hospital Medical Center (US)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2014-10-09
- Volume
- 124
- Issue
- 15
- Pages
- 2391-2399
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC4192750
- OpenAlex
- W2324521650
- Cited by
- 36
- References
- 46
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 3 · 2019: 4 · 2017: 6 · 2016: 2 · 2015: 7
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Funders
- National Heart, Lung, and Blood Institute (R01HL112719, T32HL007917)
- National Cancer Institute (P01CA066996)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- Runx transcription factors, PU.1, hematopoietic stem cells, leukemia stem cells, HSC exhaustion, transcriptional regulation, leukemia initiation
- MeSH terms
- Proto-Oncogene Protein Spi-1, Animals, Binding Sites, Hematopoietic Stem Cells, Mice, Inbred C57BL, Mutation, Promoter Regions, Genetic, Protein Binding, Proto-Oncogene Proteins, Transcription, Genetic, Neoplastic Stem Cells, Signal Transduction, Leukemia, Myeloid, Acute, Trans-Activators, Gene Expression Regulation, Leukemic, Base Pairing, Core Binding Factor alpha Subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells. https://app.cochat.ai/papers/10.1182/blood-2014-01-550855
- The paper
- Staber, P. B., Zhang, P., Ye, M., Welner, R. S., Levantini, E., Di Ruscio, A., Ebralidze, A. K., Bach, C., Zhang, H., Zhang, J., Vanura, K., Delwel, R., Yang, H., Huang, G., & Tenen, D. G. (2014). The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells. Blood. https://doi.org/10.1182/blood-2014-01-550855
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.